Carotid Intima-Media Thickness and Risk of Cardiovascular Events in High-Risk Patients

2007 ◽  
Vol 24 (1) ◽  
pp. 35-42 ◽  
Author(s):  
Kazuo Kitagawa ◽  
Hidetaka Hougaku ◽  
Hiroshi Yamagami ◽  
Hiroyuki Hashimoto ◽  
Taiji Itoh ◽  
...  
Keyword(s):  
High Risk ◽  
Cardiovascular Events ◽  
Intima Media Thickness ◽  
Carotid Intima Media Thickness ◽  
High Risk Patients ◽  
Media Thickness ◽  
Risk Patients

P187 COMMON CAROTID INTIMA-MEDIA THICKNESS IN HIGH-RISK PATIENTS IN RUSSIA AND EUROPEAN POPULATIONS

2010 ◽  
Vol 11 (2) ◽  
pp. 55
Author(s):  
I. Sobenin ◽  
V. Myasoedova ◽  
T. Kirichenko ◽  
E. Anisimova ◽  
S. Castelnuovo ◽  
...  
Keyword(s):  
High Risk ◽  
Intima Media Thickness ◽  
Carotid Intima Media Thickness ◽  
High Risk Patients ◽  
Media Thickness ◽  
Risk Patients ◽  
European Populations

scholarly journals Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events

Diabetes Care ◽  
2013 ◽  
Vol 36 (9) ◽  
pp. 2466-2474 ◽  
Author(s):  
Eva M. Lonn ◽  
Jackie Bosch ◽  
Rafael Diaz ◽  
Patricio Lopez-Jaramillo ◽  
Ambady Ramachandran ◽  
...  
Keyword(s):  
High Risk ◽  
Insulin Glargine ◽  
Cardiovascular Events ◽  
Intima Media Thickness ◽  
Carotid Intima Media Thickness ◽  
Media Thickness

AB0359 Strong impact of anti-rheumatic drugs on intima media thickness in high-risk patients

2013 ◽  
Vol 71 (Suppl 3) ◽  
pp. 658.7-658
Author(s):  
B. Kisiel ◽  
R. Kruszewski ◽  
A. Juszkiewicz ◽  
A. Bachta ◽  
K. Kłos ◽  
...  
Keyword(s):  
High Risk ◽  
Intima Media Thickness ◽  
Strong Impact ◽  
High Risk Patients ◽  
Media Thickness ◽  
Risk Patients

2-OR: Impact of N Terminal Pro B-Type Natriuretic Peptide and High Sensitivity Cardiac Troponin on the Prediction of Death and Cardiovascular Events in High-Risk Patients with Type 2 Diabetes

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 2-OR
Author(s):  
MARCUS V.B. MALACHIAS ◽  
PARDEEP JHUND ◽  
BRIAN CLAGGETT ◽  
MAGNUS O. WIJKMAN ◽  
RHONDA BENTLEY-LEWIS ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
High Risk ◽  
Natriuretic Peptide ◽  
Cardiac Troponin ◽  
Cardiovascular Events ◽  
High Sensitivity ◽  
High Risk Patients ◽  
Risk Patients

scholarly journals Clinical and therapeutic value of carotid intima-media thickness

2015 ◽  
Vol 76 (3) ◽  
Author(s):  
Enrico Vassallo ◽  
Francesca Musella ◽  
Susanna Mosca ◽  
Laura Casaretti ◽  
Roberto Formisano ◽  
...  
Keyword(s):  
Cardiovascular Events ◽  
Intima Media Thickness ◽  
Surrogate Endpoint ◽  
Carotid Intima Media Thickness ◽  
Risk Level ◽  
Media Thickness ◽  
Cardiovascular Therapy ◽  
Inter Observer Variability ◽  
The Status ◽  
Prevention Studies

Carotid Intima Media Thickness (IMT) has been widely used to predict cardiovascular events in primary and secondary prevention studies. Yet, the power of IMT to reclassify risk level on top of conventional risk assessment based on classical risk factors remains unsettled. In fact, recent data indicate that the prognostic power of IMT is lower than that provided by the identification of carotid plaques. The role of IMT as surrogate endpoint to assess the efficacy of cardiovascular protective therapies is also still debated. In fact, no studies have ever been designed and powered to show a relationship between changes in carotid IMT during follow-up and cardiovascular events. Recently, two metaanalysis of trials using IMT as surrogate endpoint failed to demonstrate an association between IMT regression and cardiovascular events. The reasons for the lack of predictive role for changes in IMT are uncertain. It has been shown that IMT is not a pure atherosclerotic index, being substantially affected by age and hemodynamic factors including blood pressure and vessel wall shear stress. In addition, the status of carotid vessels does not strictly reflect that of coronary arteries. Finally, intra and inter-observer variability of measurements may further limit the association between IMT changes in individual patients and cardiovascular risk. Thus, IMT represents a valuable risk marker in population studies but its role for tailoring cardiovascular therapy in clinical practice remains currently uncertain.

Sign in / Sign up

Export Citation Format

Share Document